Senior Regulatory Affairs Manager, Organon, 30 Huson st, Jersey City, NJ, 07904, USA
*Corresponding author. E-mail address: ramanijonali@gmail.com (J Ramani)
Online Published on 20 January, 2026.
A more cooperative paradigm is replacing the days of strictly sequential, nation-by-nation drug approvals. Navigating the terrain of international cooperation is now a core competency for the modern regulatory professional rather than a specialized skill. This article goes into detail about three collaborative models that could change the way regulatory affairs professionals work: the Access Consortium, Project Orbis, and Project Optimus. It breaks down the different ways that Access and Orbis share work, which are changing the timelines for submissions, and compares them to Project Optimus, a scientific project that is fundamentally changing the DNA of oncology development. This paper goes beyond merely describing the programs to examine how they operate, what strategic trade-offs they entail, and where they might be able to exert greater influence. The goal is to provide organizations with the information they need to navigate this new, collaborative world and transform regulatory complexity into a competitive edge.
Collaborative review, Project Orbis, Project Optimus, Access Consortium, Global regulatory strategy, Oncology